Ardelyx (ARDX) Net Equity Issued and Repurchased (2013 - 2023)

Ardelyx (ARDX) posted Net Equity Issued and Repurchased of -$12000.0 for Q4 2023, down 100.02% on a QoQ basis from $58.4 million in Q3 2023, and down 100.06% year-over-year from $18.8 million in Q4 2022.

Ardelyx (ARDX) Net Equity Issued and Repurchased (2013 - 2023) Analysis & Trends

Ardelyx's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at -$12000.0 for Q4 2023.

  • Quarterly Net Equity Issued and Repurchased fell 100.06% year-over-year to -$12000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$12000.0 (down 100.01% YoY) and the FY2023 annual result came in at $119.2 million, up 66.47% from the prior year.
  • Net Equity Issued and Repurchased was -$12000.0 for Q4 2023 at Ardelyx, down from $58.4 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $134.9 million in Q4 2019 and bottomed at -$12000.0 in Q4 2023.
  • A 5-year average of $33.2 million and a median of $23.3 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
  • Peak annual rise in Net Equity Issued and Repurchased reached 776.54% in 2023, while the deepest fall reached 100.06% in 2023.
  • Ardelyx's Net Equity Issued and Repurchased stood at $134.9 million in 2019, then sank by 83.91% to $21.7 million in 2020, then increased by 15.21% to $25.0 million in 2021, then declined by 24.88% to $18.8 million in 2022, then slumped by 100.06% to -$12000.0 in 2023.
  • Business Quant data shows ARDX's Net Equity Issued and Repurchased at -$12000.0 in Q4 2023, $58.4 million in Q3 2023, and $11.6 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 141.90 Mn
10 Ardelyx 1.24 Bn 999.81 Mn 89.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 -12,000.00
Dec 31, 2023 -12,000.00
Sep 30, 2023 58.40 Mn
Sep 30, 2023 58.40 Mn
Jun 30, 2023 11.60 Mn
Jun 30, 2023 11.60 Mn
Mar 31, 2023 51.90 Mn
Mar 31, 2023 51.90 Mn
Dec 31, 2022 18.78 Mn
Dec 31, 2022 18.78 Mn
Sep 30, 2022 35.10 Mn
Sep 30, 2022 35.10 Mn
Jun 30, 2022 12.56 Mn
Jun 30, 2022 12.56 Mn
Mar 31, 2022 5.92 Mn
Mar 31, 2022 5.92 Mn
Dec 31, 2021 25.00 Mn
Dec 31, 2021 25.00 Mn
Sep 30, 2021 4.74 Mn
Sep 30, 2021 4.74 Mn